Kuritzky Louis, Huynh Zune, Arcenas Rodney, Hansra Avneet, Shah Roma, Yang Baiyu, Lillis Rebecca
Department of Community Health and Family Medicine, University of Florida, Gainesville, Florida, USA.
Clinical Faculty, University of Central Florida/Hospital Corporation of America Family Medicine Residency, Gainesville, Florida, USA.
Postgrad Med. 2023 Nov;135(8):809-817. doi: 10.1080/00325481.2023.2280439. Epub 2024 Jan 10.
Sexually transmitted infection (STI) diagnosis is complicated as these infections can present with lower genitourinary tract symptoms (LGUTS) that overlap with other disorders, i.e. urinary tract infections (UTIs). The study's objective was to determine potential missed STI diagnoses from patients presenting with LGUTS in the US between January 2010 and December 2019.
The de-identified insurance claims data from the IBM® MarketScan® Research Databases were collected from patients (14-64 years old) who presented with LGUTS, which could be caused by an STI. A 'GAP' cohort was created, consisting of episodes with potentially delayed STI ( [CT]/ [NG]) treatment. The intention was to capture episodes where an STI was not initially suspected. Four subgroups were defined depending on the treatment received (fluoroquinolone; azithromycin and/or doxycycline; cephalosporins; gentamicin and azithromycin).
The GAP cohort consisted of 833,574 LGUTS episodes from the original cohort (23,537,812 episodes). Post-index CT/NG testing was carried out for 4.6% and 5.4% of the episodes from men and women, respectively. There were ≥2 return visits for 16.1% and 15.8% of the episodes from men and women, respectively. A substantial percentage of episodes from men (52.1%) and women (68.3%) were diagnosed with a UTI and/or acute cystitis at the index prior to receiving post-index STI treatment. Other top conditions diagnosed at index for men were dysuria (25.8% of the episodes), orchitis/epididymitis (14.3% of the episodes), and acute prostatitis (10.1% of the episodes), and for women were dysuria (24.2% of the episodes), vaginitis/vulvitis/vulvovaginitis (11.7% of the episodes), and cervicitis (3.3% of the episodes).
These findings highlight delayed STI antibiotic treatment and low rates of CT/NG testing, suggesting late STI consideration and suboptimal diagnosis. Additionally, our study illustrates the importance of accurately diagnosing and treating STIs in patients with LGUTS and associated conditions, to avoid antibiotic misuse and complications from delayed administration of appropriate treatment.
性传播感染(STI)的诊断较为复杂,因为这些感染可能表现为下泌尿生殖道症状(LGUTS),与其他疾病(如尿路感染(UTIs))症状重叠。本研究的目的是确定2010年1月至2019年12月期间美国出现LGUTS症状的患者中可能被漏诊的STI情况。
从IBM® MarketScan®研究数据库中收集了去识别化的保险理赔数据,这些数据来自出现可能由STI引起的LGUTS症状的患者(年龄在14 - 64岁之间)。创建了一个“GAP”队列,由可能延迟进行STI(沙眼衣原体/淋病奈瑟菌)治疗的病例组成。目的是捕捉最初未怀疑患有STI的病例。根据接受的治疗(氟喹诺酮类;阿奇霉素和/或多西环素;头孢菌素类;庆大霉素和阿奇霉素)定义了四个亚组。
“GAP”队列包括来自原始队列(23,537,812例病例)中的833,574例LGUTS病例。索引后对男性和女性病例分别进行沙眼衣原体/淋病奈瑟菌检测的比例为4.6%和5.4%。男性和女性病例分别有16.1%和15.8%进行了≥2次复诊。在接受索引后STI治疗之前,相当比例的男性(52.1%)和女性(68.3%)病例在索引时被诊断为UTI和/或急性膀胱炎。男性索引时诊断的其他主要疾病为排尿困难(占病例的25.8%)、睾丸炎/附睾炎(占病例的14.3%)和急性前列腺炎(占病例的10.1%),女性为排尿困难(占病例的24.2%)、阴道炎/外阴炎/外阴阴道炎(占病例的11.7%)和宫颈炎(占病例的3.3%)。
这些发现凸显了STI抗生素治疗的延迟以及沙眼衣原体/淋病奈瑟菌检测率较低,表明对STI的考虑较晚且诊断不理想。此外,我们的研究说明了准确诊断和治疗患有LGUTS及相关疾病患者的STI的重要性,以避免抗生素的滥用以及因延迟给予适当治疗而引发的并发症。